<VariationArchive VariationID="2636752" VariationName="NM_000254.3(MTR):c.2799_2803del (p.Ala935fs)" VariationType="Deletion" Accession="VCV002636752" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-19" DateCreated="2023-11-20" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2802333" VariationID="2636752">
      <GeneList>
        <Gene Symbol="MTR" FullName="5-methyltetrahydrofolate-homocysteine methyltransferase" GeneID="4548" HGNC_ID="HGNC:7468" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q43</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="236795281" stop="236903981" display_start="236795281" display_stop="236903981" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="236958580" stop="237067280" display_start="236958580" display_stop="237067280" Strand="+" />
          </Location>
          <OMIM>156570</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000254.3(MTR):c.2799_2803del (p.Ala935fs)</Name>
      <CanonicalSPDI>NC_000001.11:236886311:AAGTCAAG:AAG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q43</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="236886312" stop="236886316" display_start="236886312" display_stop="236886316" variantLength="5" positionVCF="236886311" referenceAlleleVCF="TAAGTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="237049612" stop="237049616" display_start="237049612" display_stop="237049616" variantLength="5" positionVCF="237049611" referenceAlleleVCF="TAAGTC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A528fs</ProteinChange>
      <ProteinChange>A872fs</ProteinChange>
      <ProteinChange>A884fs</ProteinChange>
      <ProteinChange>A935fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.237049615_237049619del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.237049615_237049619del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.236886315_236886319del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.236886315_236886319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008959.1" sequenceAccession="NG_008959" sequenceVersion="1" change="g.96035_96039del">
            <Expression>NG_008959.1:g.96035_96039del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000254.3" sequenceAccession="NM_000254" sequenceVersion="3" change="c.2799_2803del" MANESelect="true">
            <Expression>NM_000254.3:c.2799_2803del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000245.2" sequenceAccession="NP_000245" sequenceVersion="2" change="p.Ala935fs">
            <Expression>NP_000245.2:p.Ala935fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001291939.1" sequenceAccession="NM_001291939" sequenceVersion="1" change="c.2646_2650del">
            <Expression>NM_001291939.1:c.2646_2650del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278868.1" sequenceAccession="NP_001278868" sequenceVersion="1" change="p.Ala884fs">
            <Expression>NP_001278868.1:p.Ala884fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001291940.2" sequenceAccession="NM_001291940" sequenceVersion="2" change="c.1578_1582del">
            <Expression>NM_001291940.2:c.1578_1582del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278869.1" sequenceAccession="NP_001278869" sequenceVersion="1" change="p.Ala528fs">
            <Expression>NP_001278869.1:p.Ala528fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410942.1" sequenceAccession="NM_001410942" sequenceVersion="1" change="c.2610_2614del">
            <Expression>NM_001410942.1:c.2610_2614del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397871.1" sequenceAccession="NP_001397871" sequenceVersion="1" change="p.Ala872fs">
            <Expression>NP_001397871.1:p.Ala872fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000254.3(MTR):c.2799_2803del (p.Ala935fs) AND MTR-related disorder" Accession="RCV003421021" Version="4">
        <ClassifiedConditionList TraitSetID="91347">
          <ClassifiedCondition>MTR-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000254.3(MTR):c.2799_2803del (p.Ala935fs) AND Methylcobalamin deficiency type cblG" Accession="RCV003514640" Version="1">
        <ClassifiedConditionList TraitSetID="3939">
          <ClassifiedCondition DB="MedGen" ID="C1855128">Methylcobalamin deficiency type cblG</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-11-20" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12068375</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9683607</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3939" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2775" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Functional methionine synthase deficiency type cblG</ElementValue>
                <XRef ID="MONDO:0009609" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE</ElementValue>
                <XRef Type="MIM" ID="250940" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="156570.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblG COMPLEMENTATION TYPE</ElementValue>
                <XRef Type="MIM" ID="250940" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Methylcobalamin deficiency type cblG</ElementValue>
                <XRef ID="MONDO:0009609" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HMAG</ElementValue>
                <XRef Type="MIM" ID="250940" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3577" />
                <XRef ID="3577" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <XRef ID="2170" DB="Orphanet" />
              <XRef ID="622" DB="Orphanet" />
              <XRef ID="C1855128" DB="MedGen" />
              <XRef ID="MONDO:0009609" DB="MONDO" />
              <XRef Type="MIM" ID="250940" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="91347" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70785" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MTR-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">MTR-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7696246" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="22797718|MTR-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004117745" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MTR c.2799_2803del5 variant is predicted to result in a frameshift and premature protein termination (p.Ala935Lysfs*11). This variant was reported in the compound heterozygous state along with a pathogenic variant in an individual with methionine synthase deficiency (Watkins. 2002. PubMed ID: 12068375). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-237049611-TAAGTC-T). Frameshift variants in MTR are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000254.2:c.2799_2803del5</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MTR-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7977906" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4825635|MedGen:C1855128" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004292010" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9683607</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12068375</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12068375</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala935Lysfs*11) in the MTR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTR are known to be pathogenic (PMID: 9683607, 12068375). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with MTR-related conditions (PMID: 12068375). This variant is also known as c.2796-2800delAAGTC. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.237049612_237049616del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1855128" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7977906" TraitType="Disease" MappingType="XRef" MappingValue="C1855128" MappingRef="MedGen">
        <MedGen CUI="C1855128" Name="Methylcobalamin deficiency type cblG" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7696246" TraitType="Disease" MappingType="Name" MappingValue="MTR-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="MTR-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

